79853 Anti-CD19 CAR / NFAT (Luciferase) Reporter Jurkat Cell Line (CD19 SCFV-CD28-4-1BB-CD3ζ)
- 公司名稱 BPS Bioscience Inc.
- 品牌 BPS Bioscience
- 型號 79853
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時間 2024/11/26 17:36:36
- 訪問次數(shù) 182
聯(lián)系方式:潘濤13829799985 查看聯(lián)系方式
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息,謝謝!
Anti-CD19 CAR/NFAT (Luciferase) Reporter Jurkat Cell Line (CD19 SCFV-CD28-4-1BB-CD3ζ) is a stable cell line expressing an anti-CD19 CAR and an NFAT-dependent luciferase reporter. The reporter cell line has been validated for anti- CD19 expression by flow cytometry, and for luciferase reporter activation by target cells, including the CD19 CHO cell line. Anti-CD19 CAR consists of the anti-CD19 scFv linked to 3rd generation CAR containing the CD28, 4-1BB co-stimulatory domains and the CD3ζ signaling domain.
The cell line can be used for primary screening and functional validation of anti-CD19 CAR construct and lentivirus before testing is performed in primary T cells.
Figure 1: Lenti-vector used to generate anti-CD19 CAR lentivirus.
Figure 2. Schematic of anti-CD19 CAR.
Anti-CD19 (scFv) is linked to the 3rd generation CAR with CD28 transmembrane and costimulatory domains, 4-1BB, and CD3ζ components.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
相關(guān)分類
該廠商的其他產(chǎn)品
- 79694 Anti-BCMA CAR /NFAT (Luciferase) Reporter Jurkat Cell Line
- 78611 Anti-CD20 CAR-T Cells
- 78729 Anti-Mesothelin CAR-T Cells
- 78342 B2M Knockout Jurkat Cell Line
- 79854 Anti-CD19 CAR Negative Control/NFAT (Luciferase) Reporter Jurkat Cell Line (CD19 SCFV-CD28 Transm...
- 78363 B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line
- 78391 B2M/CIITA Double Knockout THP-1 Cell Line
- 78389 B2M Knockout THP-1 Cell Line